FIBCLOT Trademark

Trademark Overview

On Wednesday, October 8, 2014, a trademark application was filed for FIBCLOT with the United States Patent and Trademark Office. The USPTO has given the FIBCLOT trademark a serial number of 79156692. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 22, 2022. This trademark is owned by LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The FIBCLOT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit; blood proteins naturally occurring or of transgenic origin, or synthetic or semi-synthetic preparations for therapeutic use; injectable pharmaceuticals for use in the treatment of inherited and acquired fibrinogen deficit
fibclot

General Information

Serial Number79156692
Word MarkFIBCLOT
Filing DateWednesday, October 8, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 22, 2022
Registration Number4824409
Registration DateTuesday, October 6, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit; blood proteins naturally occurring or of transgenic origin, or synthetic or semi-synthetic preparations for therapeutic use; injectable pharmaceuticals for use in the treatment of inherited and acquired fibrinogen deficit
Pseudo MarkFIB CLOT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLES ULIS F-91940
FR
Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLES ULIS F-91940
FR

Trademark Events

Event DateEvent Description
Thursday, December 11, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 2, 2015NON-FINAL ACTION WRITTEN
Tuesday, December 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 20, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, January 28, 2015ASSIGNED TO EXAMINER
Tuesday, February 3, 2015REFUSAL PROCESSED BY MPU
Tuesday, May 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 3, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 3, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 27, 2015REFUSAL PROCESSED BY IB
Tuesday, May 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 19, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 27, 2015CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Monday, June 15, 2015ASSIGNED TO LIE
Monday, June 15, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 17, 2015NOTIFICATION PROCESSED BY IB
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 3, 2015CORRECTION TRANSACTION RECEIVED FROM IB
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, January 6, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2016GENERIC MADRID TRANSACTION CREATED
Tuesday, March 8, 2016GENERIC MADRID TRANSACTION SENT TO IB
Thursday, May 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 13, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, February 24, 2025GENERIC MADRID TRANSACTION CREATED
Monday, February 24, 2025GENERIC MADRID TRANSACTION SENT TO IB
Monday, February 24, 2025GENERIC MADRID TRANSACTION CREATED
Monday, February 24, 2025INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, June 17, 2024INTERNATIONAL REGISTRATION RENEWED
Friday, April 22, 2022CANCELLED SECTION 71
Thursday, December 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, March 11, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, May 7, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

fibclot fibrinogen deficit synthetic inherited acquired preparations treatment pharmaceuticals semi injectable